<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Lamin A-processing pathway" Version="20180423" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">All lamins, except lamin C, contain a CaaX tail. This tail is comprised of respectively cysteine, two aliphatic amino acids and any amino acid with a COOH-terminal (variable). Aliphatic amino acids are nonpolar and hydrophobic and include glycine, alanine, valine, leucine and isoleucine. This structure acts as recognition point for a sequence of modifications. First the terminal cysteine is farnesylated by farnesyl transferase, where a isoprenyl group is added to the cysteine residue -also called isoprenylation. This is followed by proteolytic cleavage of the aaX part by Zmpste24 and methylation (CH3) of cysteine. Isoprenylation and methylation are both necessary for the localization of lamin A and B-type lamins in to the INM. Until this point processing of lamin A and type-B lamins is similar. While in type-B lamins the isoprenyl group remains attached to the cysteine, lamin A has a second cleavage site to cleave off an additional 15 amino acids upstream of the cysteine. This cleavage is also done by Zmpste24 and takes place at INM. When these 15 amino acids, 18 in total including aaX, are cleaved off mature lamin A is produced (1,2). Lamin processing is involved in progeria. 
</Comment>
  <BiopaxRef>e71</BiopaxRef>
  <BiopaxRef>a38</BiopaxRef>
  <Graphics BoardWidth="1283.4722222222222" BoardHeight="484.8689558125689"/>
  <DataNode TextLabel="C" GraphId="a781e" Type="Metabolite">
    <Comment>Cysteine</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Progeria syndrome" GraphId="f0a02" Type="Pathway">
    <Graphics ShapeType="RoundedRectangle" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="15 amino acids" GraphId="c5911" GroupRef="cd142">
        </DataNode>
  <DataNode TextLabel="ZMPSTE24" GraphId="fa3ca" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Farnesyl transferase" GraphId="d85dc" Type="Protein">
        </DataNode>
  <DataNode TextLabel="LMNA" GraphId="b7f8c" Type="GeneProduct">
    <Graphics FillColor="Transparent"/>
    </DataNode>
  <DataNode TextLabel="aaX" GraphId="f5d54" Type="Protein">
        </DataNode>
  <DataNode TextLabel="CAAX prenyl protease 1 homolog" GraphId="f8dfc" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Mature lamin A" GraphId="b79fa" Type="Protein">
    <Comment>72 kDa</Comment>
        </DataNode>
  <DataNode TextLabel="Protein-S-isoprenylcysteine O-methyltransferase" GraphId="b98d9" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Pre-lamin A" GraphId="da7c2" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Pre-lamin A" GraphId="d9e53" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="C" GraphId="f5553" Type="Metabolite">
    <Comment>Cysteine</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Pre-lamin A" GraphId="fa7f8" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="CAAX prenyl protease 1 homolog" GraphId="fc461" Type="Protein">
        </DataNode>
  <DataNode TextLabel="ZMPSTE24" GraphId="a1db2" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="C" GraphId="ede4f" Type="Metabolite" GroupRef="cd142">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Pre-lamin A" GraphId="fed3a" Type="GeneProduct">
        </DataNode>
  <State GraphRef="da7c2" TextLabel="" GraphId="e1ab2">
    <Comment>Farnesyl group</Comment>
    <Graphics FillColor="00cccc" ShapeType="Oval" Color="00cccc"/>
    </State>
  <State GraphRef="d9e53" TextLabel="" GraphId="d75b6">
    <Comment>Farnesyl group</Comment>
    <Graphics FillColor="00cccc" ShapeType="Oval" Color="00cccc"/>
    </State>
  <State GraphRef="fa7f8" TextLabel="" GraphId="a9e7a">
    <Comment>Farnesyl group</Comment>
    <Graphics FillColor="00cccc" ShapeType="Oval" Color="00cccc"/>
    </State>
  <State GraphRef="fa7f8" TextLabel="" GraphId="e82b8">
    <Comment>CH3</Comment>
    <Graphics FillColor="ff3300" ShapeType="Oval" Color="ff3300"/>
    </State>
  <State GraphRef="ede4f" TextLabel="" GraphId="ea58d">
    <Graphics FillColor="ff3300" ShapeType="Oval" Color="ff3300"/>
    </State>
  <State GraphRef="ede4f" TextLabel="" GraphId="fb598">
    <Graphics FillColor="00cccc" ShapeType="Oval" Color="00cccc"/>
    </State>
  <Interaction GraphId="id45c96a96">
    <Graphics>
      <Point GraphRef="afd85"/>
      <Point GraphRef="f5d54" ArrowHead="mim-cleavage"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id774d50f8">
    <Graphics>
      <Point GraphRef="fab72"/>
      <Point GraphRef="d9e53" ArrowHead="mim-conversion"/>
      <Anchor Position="0.7227507309596743" Shape="None" GraphId="c0cac"/>
      <Anchor Position="0.8434692571869398" Shape="None" GraphId="afd85"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id98265bf8">
    <Graphics>
      <Point GraphRef="f8dfc"/>
      <Point GraphRef="c0cac" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id9ff51ddc">
    <Comment>If this cleavage doesn't happen, progerin is formed, leading to progeria syndrome.</Comment>
    <Graphics LineStyle="Broken" Color="ff0000">
      <Point GraphRef="c75fd"/>
      <Point GraphRef="f0a02" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8dc9b64f">
    <Graphics>
      <Point GraphRef="b98d9"/>
      <Point GraphRef="f9b47" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idfe38ef92">
    <Graphics>
      <Point GraphRef="a1db2"/>
      <Point GraphRef="fc461" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id5571503e">
    <Graphics>
      <Point GraphRef="fa3ca"/>
      <Point GraphRef="f8dfc" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idda8238c3">
    <Graphics>
      <Point GraphRef="fa7f8"/>
      <Point GraphRef="b79fa" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4365106012640112" Shape="None" GraphId="c75fd"/>
      <Anchor Position="0.6618768329731326" Shape="None" GraphId="cacbb"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id950f3d65">
    <Graphics>
      <Point GraphRef="d85dc"/>
      <Point GraphRef="f95e2" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8244c3a6">
    <Graphics>
      <Point GraphRef="fc461"/>
      <Point GraphRef="cacbb" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ida836bc32">
    <Graphics>
      <Point GraphRef="b7f8c"/>
      <Point GraphRef="fed3a" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id563b6a79">
    <Graphics>
      <Point GraphRef="d9e53"/>
      <Point GraphRef="fa7f8" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5500714841331972" Shape="None" GraphId="f9b47"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id369b51fd">
    <Graphics>
      <Point GraphRef="fed3a"/>
      <Point GraphRef="da7c2" ArrowHead="mim-conversion"/>
      <Anchor Position="0.7909451376123763" Shape="None" GraphId="f95e2"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ideaed46a2">
    <Graphics>
      <Point GraphRef="c75fd"/>
      <Point GraphRef="de62c" ArrowHead="mim-cleavage"/>
    </Graphics>
    </Interaction>
  <Label TextLabel="CaaX group" GraphId="fab72">
    <Comment>- hallmark for farnestylated proteins</Comment>
    <Graphics FillColor="ffffff" ShapeType="Rectangle"/>
  </Label>
  <Label TextLabel="CaaX group" GraphId="d544d">
    <Comment>- hallmark for farnestylated proteins</Comment>
    <Graphics FillColor="ffffff" ShapeType="Rectangle"/>
  </Label>
  <Label TextLabel="CH3" GraphId="a6864">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Farnesyl group" GraphId="d2e68">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Shape GraphId="da08e">
    <Graphics FillColor="00cccc" ShapeType="Oval" Color="00cccc"/>
  </Shape>
  <Shape GraphId="b8c29">
    <Graphics FillColor="ff3300" ShapeType="Oval" Color="ff3300"/>
  </Shape>
  <Group GroupId="cd142" GraphId="de62c" Style="Group"/>
  <InfoBox/>
  <Biopax>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >signaling pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000003</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:4</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >disease pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000013</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e71">
      <bp:ID >17660942</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing.</bp:TITLE>
      <bp:SOURCE >Cell Mol Life Sci</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Cox LS</bp:AUTHORS>
      <bp:AUTHORS >Faragher RG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >progeria</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:3911</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a38">
      <bp:ID >16816143</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Nuclear lamins: laminopathies and their role in premature ageing.</bp:TITLE>
      <bp:SOURCE >Physiol Rev</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Broers JL</bp:AUTHORS>
      <bp:AUTHORS >Ramaekers FC</bp:AUTHORS>
      <bp:AUTHORS >Bonne G</bp:AUTHORS>
      <bp:AUTHORS >Yaou RB</bp:AUTHORS>
      <bp:AUTHORS >Hutchison CJ</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>